Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuaijian Ni

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Peptide Science : an Official Publication of the European Peptide Society|May 18, 2010
The application of an aryl hydrazine linker prevents beta-elimination side products in the SPPS of C-terminal cysteine peptidesShuaijian Ni, Huibin Zhang, Wenlong Huang, et al.
International Journal of Molecular Sciences|August 3, 2017
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic PurposesShuaijian Ni, Houzong Yao, Lili Wang, et al.
Bioorganic & Medicinal Chemistry|July 29, 2008
Microwave-assisted solid phase synthesis, PEGylation, and biological activity studies of glucagon-like peptide-1(7-36) amideYushi Chi, Huibin Zhang, Wenlong Huang, et al.
International Journal of Molecular Sciences|August 26, 2017
Potential Diagnostic and Therapeutic Applications of Oligonucleotide Aptamers in Breast CancerXiaoqiu Wu, Atik Badshah Shaikh, Yuanyuan Yu, et al.
Protein and Peptide Letters|July 3, 2010
Synthesis and bioactivity evaluation of dipeptidyl peptidase IV resistant glucagon-like peptide-1 analoguesJinpei Zhou, Shuaijian Ni, Huibin Zhang, et al.
Frontiers in Cell and Developmental Biology|April 15, 2021
Targeting Strategies for Enhancing Paclitaxel Specificity in ChemotherapyYuan Ma, Sifan Yu, Shuaijian Ni, et al.
Protein and Peptide Letters|August 16, 2011
Stability and bioactivity studies on dipeptidyl peptidase IV resistant glucogan-like peptide-1 analoguesWei Chen, Yinghong Zhou, Huibin Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 17, 2020
A Loop-Based and AGO-Incorporated Virtual Screening Model Targeting AGO-Mediated miRNA-mRNA Interactions for Drug Discovery to Rescue Bone Phenotype in Genetically Modified MiceZhenjian Zhuo, Youyang Wan, Daogang Guan, et al.
Molecular Therapy. Nucleic Acids|December 11, 2023
A bimolecular modification strategy for developing long-lasting bone anabolic aptamerHuarui Zhang, Sifan Yu, Shuaijian Ni, et al.
ACS Applied Materials & Interfaces|July 1, 2020
Recent Progress in Aptamer Discoveries and Modifications for Therapeutic ApplicationsShuaijian Ni, Zhenjian Zhuo, Yufei Pan, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Peptide Science : an Official Publication of the European Peptide Society|May 18, 2010
The application of an aryl hydrazine linker prevents beta-elimination side products in the SPPS of C-terminal cysteine peptidesShuaijian Ni, Huibin Zhang, Wenlong Huang, et al.
International Journal of Molecular Sciences|August 3, 2017
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic PurposesShuaijian Ni, Houzong Yao, Lili Wang, et al.
Bioorganic & Medicinal Chemistry|July 29, 2008
Microwave-assisted solid phase synthesis, PEGylation, and biological activity studies of glucagon-like peptide-1(7-36) amideYushi Chi, Huibin Zhang, Wenlong Huang, et al.
International Journal of Molecular Sciences|August 26, 2017
Potential Diagnostic and Therapeutic Applications of Oligonucleotide Aptamers in Breast CancerXiaoqiu Wu, Atik Badshah Shaikh, Yuanyuan Yu, et al.
Protein and Peptide Letters|July 3, 2010
Synthesis and bioactivity evaluation of dipeptidyl peptidase IV resistant glucagon-like peptide-1 analoguesJinpei Zhou, Shuaijian Ni, Huibin Zhang, et al.
Frontiers in Cell and Developmental Biology|April 15, 2021
Targeting Strategies for Enhancing Paclitaxel Specificity in ChemotherapyYuan Ma, Sifan Yu, Shuaijian Ni, et al.
Protein and Peptide Letters|August 16, 2011
Stability and bioactivity studies on dipeptidyl peptidase IV resistant glucogan-like peptide-1 analoguesWei Chen, Yinghong Zhou, Huibin Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 17, 2020
A Loop-Based and AGO-Incorporated Virtual Screening Model Targeting AGO-Mediated miRNA-mRNA Interactions for Drug Discovery to Rescue Bone Phenotype in Genetically Modified MiceZhenjian Zhuo, Youyang Wan, Daogang Guan, et al.
Molecular Therapy. Nucleic Acids|December 11, 2023
A bimolecular modification strategy for developing long-lasting bone anabolic aptamerHuarui Zhang, Sifan Yu, Shuaijian Ni, et al.
ACS Applied Materials & Interfaces|July 1, 2020
Recent Progress in Aptamer Discoveries and Modifications for Therapeutic ApplicationsShuaijian Ni, Zhenjian Zhuo, Yufei Pan, et al.
Pageof 2